Evidence map›Paper›PMID 35661465›Full record

ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2022

Epidemiological and clinical characteristics of pregnant women and neonates with COVID-19 in Northwest Mexico.

Nidia Leon-Sicairos, Uriel A Angulo-Zamudio, Mireya Pacheco-Avila, Ivan Medina-Ramirez, Jorge Velazquez-Roman, Jorge Angulo-Rocha, Francisco A Martínez-Villa, Hector Flores-Villaseñor, Jesus J Martinez-Garcia, Jaime Sanchez-Cuen and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Epidemiological and clinical characteristics of pregnant women and neonates with COVID-19 in Northwest Mexico.American journal of reproductive immunology (New York, N.Y. : 1989) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Nidia Leon-SicairosCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0003-1470-3383
Uriel A Angulo-ZamudioCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0003-2733-0766
Mireya Pacheco-AvilaThe Women's Hospital, Secretariat of Health, Culiacan, Sinaloa, Mexico.
Ivan Medina-RamirezThe Women's Hospital, Secretariat of Health, Culiacan, Sinaloa, Mexico.
Jorge Velazquez-RomanCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0002-0095-6892
Jorge Angulo-RochaThe Women's Hospital, Secretariat of Health, Culiacan, Sinaloa, Mexico.ORCID 0000-0002-7573-2017
Francisco A Martínez-VillaCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0002-6074-6221
Hector Flores-VillaseñorCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0001-9734-8019
Jesus J Martinez-GarciaCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0002-9555-262X
Jaime Sanchez-CuenCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Oscar Garzon-LopezThe Women's Hospital, Secretariat of Health, Culiacan, Sinaloa, Mexico.
Martha Guel-GomezThe Women's Hospital, Secretariat of Health, Culiacan, Sinaloa, Mexico.
Hector Melesio Cuen-DiazFCA, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Mario Francisco Barajas-OlivasThe Women's Hospital, Secretariat of Health, Culiacan, Sinaloa, Mexico.
Abraham Campos-RomeroSalud Digna A.C., Culiacán, Sinaloa, México.
Jonathan Alcántar-FernándezSalud Digna A.C., Culiacán, Sinaloa, México.
Marco A Luna-Ruiz EsparzaSalud Digna A.C., Culiacán, Sinaloa, México.
Adrian Canizalez-RomanCIASaP, School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID 0000-0001-8605-0639
Universidad Autónoma de Sinaloa · MXPediatric Hospital of Sinaloa · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe SARS-CoV-2 virus, which causes COVID-19, has spread quickly worldwide, causing millions of cases and thousands of deaths. Some risk factors in the general population are related to the development of severe COVID-19 or death, but in pregnant women and neonates, the information is limited.

objectiveTo determine the epidemiological and clinical characteristics of pregnant women and neonates diagnosed with COVID-19 by RT-PCR and serological tests, and analyze the relationship between the influenza vaccination and COVID-19 symptoms in infected pregnant women in Sinaloa state.

methodsWe collected samples from 116 pregnant women and 84 neonates from the Women´s Hospital of Sinaloa. They were diagnosed with COVID-19 by RT-PCR and serological tests (IgG), and sociodemographic, clinical and laboratory parameters were recorded.

resultsA total of 11.2% (13/116) of the pregnant women were RT-PCR+, 25% (29/116) were IgG+ and 4.3% (5/116) were positive for both tests. Symptoms such as rhinorrhea (P = .04), cough (P = .02) and polypnea (P = .04) in pregnant women were related to COVID-19, also leukocyte index was higher in pregnant women with COVID-19 (P = .03), but the associations were lost after the Bonferroni correction. No laboratory parameters or underlying diseases were associated with COVID-19, and most infected pregnant women had mild cases. We found an association between the influenza vaccine and less common COVID-19 symptoms in pregnant women who were infected (P = .01). A total of 7.2% (6/84) of neonates were RT-PCR+, 35.7% (30/84) were IgG+, and there were no symptoms or underlying diseases associated with neonates who were infected. In conclusion, this work demonstrated that some symptoms were related to COVID-19, most pregnant women and neonates had mild cases, and the influenza vaccine could decrease the severity of COVID-19 cases in pregnant women.

Indexed as

COVID-19Influenza VaccinesPregnancy Complications, InfectiousFemaleHumansImmunoglobulin GInfant, NewbornMexicoPregnancyPregnant PeopleSARS-CoV-2Immunoglobulin GInfluenza VaccinesCOVID-19IgGneonatespregnant womenRT-PCR

Identifiers

PMID35661465
PMCPMC9348056
OpenAlexW4281720669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.